Intec Pharma

$4.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-2.19%) Today

-$0.05 (-1.12%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Intec Pharma and other stocks, options, and ETFs commission-free!

About NTEC

Intec Pharma Ltd. Ordinary Shares, also called Intec Pharma, is a clinical-stage biopharmaceutical company engaging in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvi Joseph in 2000 and is headquartered in Jerusalem, Israel. The listed name for NTEC is Intec Pharma Ltd. Ordinary Shares.

CEO

Jeffrey A. Meckler

Employees

Headquarters

Jerusalem, Jerusalem

Founded

2000

Market Cap

17.11M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.09M

High Today

$4.58

Low Today

$4.40

Open Price

$4.50

Volume

187.22K

52 Week High

$15.82

52 Week Low

$2.20

Collections

NTEC Earnings

-$0.95

-$0.63

-$0.32

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, Pre-Market